
|Articles|March 1, 1997
The American Journal of Managed Care
- March 1997
- Volume 3
- Issue 3
A Cost/Efficacy Analysis of Oral Antifungals Indicated for the Treatment of Onychomycosis: Griseofulvin, Itraconazole, and Terbinafine
Advertisement
Articles in this issue
over 28 years ago
The Political Economy of Capitated Managed Careover 28 years ago
Appropriate and Necessary Healthcare: New Language for a New Eraover 28 years ago
Managing Asthma CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD
3
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
4
Interventions to Advance Equity in Pediatric Cardiovascular Care
5
















































